Showing results (51-60 of 219) with videos related to
Sort By:
Pageof 22
Current Pharmaceutical Design|March 28, 2013
Systems biology approaches to pancreatic cancer detection, prevention and treatmentOsama M Alian, Philip A Philip, Fazlul H Sarkar, et al.International Journal of Oncology|December 4, 2009
Angiogenesis: an update and potential drug approaches (review)Maen Abdelrahim, Santhi Konduri, Riyaz Basha, et al.Seminars in Cancer Biology|January 26, 2016
F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunitiesAmmar Sukari, Irfana Muqbil, Ramzi M Mohammad, et al.Journal of Clinical Medicine|June 21, 2016
The Role of microRNAs in the Diagnosis and Treatment of Pancreatic AdenocarcinomaMaria Diab, Irfana Muqbil, Ramzi M Mohammad, et al.Seminars in Cancer Biology|February 16, 2019
Ras and exosome signalingRachel E Sexton, Gabriel Mpilla, Steve Kim, et al.Cancer|March 17, 2009
Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell linesShirish M Gadgeel, Shadan Ali, Philip A Philip, et al.Expert Opinion on Emerging Drugs|September 4, 2010
Emerging Bcl-2 inhibitors for the treatment of cancerAsfar S Azmi, Zhiwei Wang, Philip A Philip, et al.American Journal of Physiology. Cell Physiology|October 24, 2022
Role of noncoding RNAs in pancreatic ductal adenocarcinoma associated cachexiaMd Hafiz Uddin, Ramzi M Mohammad, Philip A Philip, et al.Molecular Cancer Therapeutics|November 3, 2010
Proof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinationsAsfar S Azmi, Zhiwei Wang, Philip A Philip, et al.Cancer Research|August 3, 2005
Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cellsYiwei Li, Fakhara Ahmed, Shadan Ali, et al.Pageof 22